Optimizing INtrinsic Capacity for Functional INdependence and to Impede FrailTY in Older Adults: Adaptation of the WHO-ICOPE for Healthy Ageing in Singapore

NCT07477561 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2026-04-17

No results posted yet for this study

Summary

The goal of this intervention study is to screen and identify frailty and decline in intrinsic capacity (physical and mental capacities) in community-dwelling older adults in Singapore, and to evaluate whether early identification and targeted interventions can improve health outcomes and support healthy ageing. The main questions it aims to answer are:

* Can combined frailty and intrinsic capacity screening with targeted interventions prevent or reduce functional decline in older adults, as measured by changes in life space mobility?
* Will at least 80% of screened older adults adhere to recommended care pathways and interventions?
* Can this screening and intervention programme demonstrate sustainability through continued community participation and recruitment of new partner organizations beyond the initial implementation phase? The investigators will compare an intervention group (receiving immediate assessment and clinical referrals based on identified needs) to a wait-list control group (receiving the same interventions 12 months later) to see if early intervention leads to better health outcomes and quality of life.

Participants will:

* Attend 4 study visits over 2 years (at 6-monthly intervals in the first year, with final assessment at end of year 2), each lasting up to 2 hours.
* Undergo comprehensive screening assessments including mobility, cognition, mental health, hearing, vision, and nutritional status.
* Receive 2 follow-up phone calls at 3-month and 9-month intervals to monitor progress.
* If in the intervention group: receive personalized referrals for further care (which may include comprehensive geriatric assessment, primary care reviews, rehabilitation, or dietitian consultations) and guidance on using a mobile health monitoring application.
* If in the wait-list control group: receive the same interventions after their 3rd study visit (12 months later).

Conditions

  • Frailty in Older Adults
  • Intrinsic Capacity
  • Age-related Functional Decline
  • Healthy Ageing

Interventions

OTHER

INFINITY-ICOPE programme

The INFINITY-ICOPE programme will involve (i) integrated frailty and intrinsic capacity screening, (ii) referral to comprehensive geriatric assessment for frail participants or pathways adapted from the WHO-ICOPE approach for non-frail seniors with intrinsic capacity decline, (iii) 6-monthly self-monitoring for IC and frailty supported through the ENGAGE app and SCREENii.

Sponsors & Collaborators

  • Singapore Health Services

    collaborator OTHER
  • Singapore General Hospital

    collaborator OTHER
  • Changi General Hospital

    collaborator OTHER
  • SingHealth Polyclinics

    collaborator OTHER
  • National Dental Centre, Singapore

    collaborator OTHER
  • Geriatric Education and Research Institute

    collaborator OTHER_GOV
  • National University of Singapore

    collaborator OTHER
  • Singapore University of Social Sciences

    collaborator OTHER
  • Sengkang General Hospital

    lead OTHER

Principal Investigators

  • Laura Bee Gek Tay · Sengkang General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-17
Primary Completion
2027-06-30
Completion
2028-01-15

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07477561 on ClinicalTrials.gov